key: cord-1010622-x3sc7g7q
authors: Wharton, Benjamin R.; Doan, Kent C.; Wolcott, Michelle L.
title: Shoulder Injury Related to COVID-19 Vaccine Administration: A Case Report
date: 2021-12-04
journal: JSES reviews, reports, and techniques
DOI: 10.1016/j.xrrt.2021.10.005
sha: e9b6c8f25ff273e19a71e3a472f9dbb6182d1c14
doc_id: 1010622
cord_uid: x3sc7g7q

nan

With the rollout of the most ambitious worldwide vaccine initiative of all time to combat the 4 COVID-19 Pandemic, the medical community has been faced with more challenges than ever 5 before. Vaccine hesitancy has been among one of the leading threats to the global vaccination 6 effort 10 , and this is presumably due to concerns with vaccine side effects. As side effects are 7 encountered, the healthcare community has a duty to quickly disseminate these risks to try and 8 mitigate their potential harms. One of the most common side effects of all intra-muscular 9

vaccines is a transient local inflammatory reaction, which is maintained in the novel COVID-19 10 vaccination 10 . Less common however are reactions known as Shoulder Injury Related to 11

Vaccine Administration (SIRVA), that have only recently been described in mRNA vaccines. 12

We will be presenting a case of SIRVA in a young healthy healthcare worker as a result of 13 inappropriate site of administration of the Moderna Vaccine. 14 Moderna COVID-19 vaccine 2.5 weeks prior. Upon injection, he noted the location of the 24 injection site seemed unusually proximal in the deltoid, just distal to his acromion. He had 25 experienced normal postvaccination symptoms including erythema, pain, and induration initially 26 over the first 24 hours. This progressed with continued weakness and pain following the one-day 27 mark, eventually limiting his ability to use his left hand for his job with no improvement over the 28 next 2.5 weeks. He denied any type of neurologic deficits, but was restricted by shoulder 29 stiffness and overall pain. The patient described his pain and stiffness as constant. The symptoms 30 bothered him at night, with exertion, and at rest. They were both localized to the lateral 31 shoulder and was primarily noted during movements of shoulder abduction and flexion. The 32 patient was limited in his ability to work. His only previous treatment included anti-33

inflammatories. Overall, the problem significantly impacted his quality of life. 34

When examining the left shoulder, there was no ecchymosis, nor was there any discernable 36 atrophy. There was mild diffuse tenderness to palpation. The patient's active range of motion 37 with abduction and forward elevation was limited to 80 degrees secondary to pain, however his 38 passive motion was preserved. He did also have subacromial impingement signs with a positive 39 was obtained, following clinical exclusion of other shoulder diagnoses, which showed marginal 48 tendonitis of the supraspinatus tendon and slight edema in the subacromial area, which is 49 nonspecific yet often associated with subacromial bursitis (Image A). MRI findings in SIRVA 50 cases typically present with fluid collections in the deltoid or overlying the rotator cuff tendons, 51 bursitis, fluid "greater than typically seen" within the shoulder bursa, tendonitis, and rotator cuff 52 tears 1 . This presentation is unusual in comparison to normal post-vaccination MRI findings that 53 often include minor fluid accumulations of the deltoid and greater shoulder region 1 . 54 55 Based on the history, imaging, and physical exam findings, we made the diagnosis of SIRVA 56 secondary to COVID-19 vaccine administration. After consultation with the patient, we decided 57 that the next reasonable step would be to treat his shoulder symptoms with a subacromial 58 corticosteroid 7 . The AAOS Patient Safety Committee recommends avoiding musculoskeletal 59 corticosteroid injections for two weeks before and one week after COVID vaccine 60 administration, but there is no direct evidence of the impact of corticosteroid injections on 61 vaccine efficacy outside of that timeline. In standard sterile fashion, the left subacromial 62 space was injected with 20 mg Triamcinolone with 9 cc of 1% Xylocaine without epinephrine. shoulder pain, weakness, and motion deficits following his vaccination due to incorrect 105 administration of the antigens and adjuvants into the subacromial space producing a robust 106 inflammatory response. This is the one of the first reported cases of SIRVA following COVID-107 disability and vaccine hesitancy related to this pathology. Correct administration technique and 115 location is detailed below (Image B). 116

SIRVA is an ongoing issue that results from imprecise anatomic vaccine administration to the 119 subacromial space instead of intra-muscularly in the deltoid muscle bulk 6 . Although still quite 120 rare, it is important that instances of imprecise vaccine administration leading to SIRVA are 121 documented in order to promote understanding of possible causes of obscure shoulder pain 122 following vaccine administration 3 . This will help prevent this avoidable side effect and mitigate 123 vaccine hesitancy in the global population. In the case of our patient, the injury led to weeks of 124 pain, weakness, and disability that went unresolved prior to corticosteroid injection therapy. Past 125 literature suggests tendonitis/ subacromial bursitis is associated in approximately half of 126 documented SIRVA instances, much like that of our patient who received the novel COVID-19 127 vaccination from Moderna 1 . Without intervention, various shoulder symptoms can continue 128 months to years later without natural resolution 9 . Overall, SIRVA is a preventable side effect 129 with serious complications that can be addressed with the correct training and education to those 130 administering vaccines 2 , and it is a treatable condition if recognized by medical providers. By 131 recognizing, treating, and preventing this pathology, medical professionals can directly help 132 prevent harm to their patients and more effectively combat the COVID-19 pandemic. 133

Getting it in the right spot: Shoulder injury related to 139 vaccine administration (SIRVA) and other injection site events

A "needling" problem: shoulder injury related to vaccine 142 administration

Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2

Subdeltoid/subacromial bursitis associated with influenza vaccination

Don't aim too high: Avoiding 150 shoulder injury related to vaccine administration

With Corticosteroid Injections: A Case Series

Risk of bursitis and 155 other injuries and dysfunctions of the shoulder following vaccinations. Vaccine

Shoulder Injury Related to Vaccine

Administration (SIRVA): An Occupational Case Report. Workplace Health Saf